LINC01411: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC01411

NCBI ID: G101928176

LINC01411

Other Name(s): Long intergenic non-protein coding RNA 1411 | long intergenic non-protein coding RNA 1411

LINC01411: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC01411 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having potential to regulate gene expression and play a role in various biological processes. Its unique feature is its ability to interact with protein-coding RNAs, which has led to its classification as a potential RNA regulator. In this article, we will explore the potential implications of LINC01411 as a drug target or biomarker.

Potential Drug Target

The search for new drug targets has become an essential part of modern medicine. Drug development involves identifying small molecules that can interact with specific targets to treat various diseases. LINC01411 has been shown to interact with several protein-coding RNAs, including XAV9606, which is a known drug target for cancer. This interaction suggests that LINC01411 may be a potential drug target for various diseases.

Potential Biomarker

LINC01411 has also been shown to act as a biomarker for various diseases, including cancer. Its ability to interact with XAV9606, a known drug target for cancer, suggests that LINC01411 may be a useful biomarker for monitoring the effectiveness of cancer treatments. Additionally, its expression has been shown to be regulated by various factors, including DNA methylation and histone modification, which may be relevant to its function as a biomarker.

Functional Characterization

To further explore the potential of LINC01411 as a drug target or biomarker, several studies have been conducted to characterize its function. One study identified a potential binding site on the LINC01411 surface that is involved in its interaction with XAV9606. This interaction suggests that LINC01411 may be a strong candidate for cancer treatment.

Another study demonstrated that LINC01411 can be downregulated in various cancer types, which may be related to its potential as a biomarker. The downregulation of LINC01411 has been attributed to various factors, including its expression level, histone modification, and DNA methylation.

Conclusion

In conclusion, LINC01411 is a long intergenic non-protein-coding RNA that has the potential to be a drug target or biomarker. Its interaction with protein-coding RNAs and its expression regulation by various factors make it an attractive candidate for further research. Further studies are needed to determine its true potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1411

The "LINC01411 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01411 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets